Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.46 EUR
43.63 M EUR
513.50 M EUR
31.12 M
About Collegium Pharmaceutical, Inc.
Sector
CEO
Vikram Karnani
Headquarters
Stoughton
Website
Founded
2002
FIGI
BBG00D1LYFJ2
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
COLL5756983
Collegium Pharmaceutical, Inc. 2.875% 15-FEB-2029Yield to maturity
0.90%
Maturity date
Feb 15, 2029
Explore more bonds
Frequently Asked Questions
The current price of 354 is 29.00 EUR — it has decreased by −1.34% in the past 24 hours. Watch COLLEGIUM PHARMACEUTICAL INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange COLLEGIUM PHARMACEUTICAL INC stocks are traded under the ticker 354.
354 stock has risen by 5.00% compared to the previous week, the month change is a −8.13% fall, over the last year COLLEGIUM PHARMACEUTICAL INC has showed a 23.93% increase.
We've gathered analysts' opinions on COLLEGIUM PHARMACEUTICAL INC future price: according to them, 354 price has a max estimate of 47.44 EUR and a min estimate of 35.11 EUR. Watch 354 chart and read a more detailed COLLEGIUM PHARMACEUTICAL INC stock forecast: see what analysts think of COLLEGIUM PHARMACEUTICAL INC and suggest that you do with its stocks.
354 stock is 2.08% volatile and has beta coefficient of 0.38. Track COLLEGIUM PHARMACEUTICAL INC stock price on the chart and check out the list of the most volatile stocks — is COLLEGIUM PHARMACEUTICAL INC there?
Today COLLEGIUM PHARMACEUTICAL INC has the market capitalization of 937.40 M, it has increased by 3.45% over the last week.
Yes, you can track COLLEGIUM PHARMACEUTICAL INC financials in yearly and quarterly reports right on TradingView.
COLLEGIUM PHARMACEUTICAL INC is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
354 earnings for the last quarter are 1.45 EUR per share, whereas the estimation was 1.43 EUR resulting in a 1.16% surprise. The estimated earnings for the next quarter are 1.42 EUR per share. See more details about COLLEGIUM PHARMACEUTICAL INC earnings.
COLLEGIUM PHARMACEUTICAL INC revenue for the last quarter amounts to 143.07 M EUR, despite the estimated figure of 139.80 M EUR. In the next quarter, revenue is expected to reach 169.87 M EUR.
354 net income for the last quarter is 8.38 M EUR, while the quarter before that showed 18.30 M EUR of net income which accounts for −54.20% change. Track more COLLEGIUM PHARMACEUTICAL INC financial stats to get the full picture.
No, 354 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 197.00 employees. See our rating of the largest employees — is COLLEGIUM PHARMACEUTICAL INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COLLEGIUM PHARMACEUTICAL INC EBITDA is 324.65 M EUR, and current EBITDA margin is 57.29%. See more stats in COLLEGIUM PHARMACEUTICAL INC financial statements.
Like other stocks, 354 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COLLEGIUM PHARMACEUTICAL INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COLLEGIUM PHARMACEUTICAL INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COLLEGIUM PHARMACEUTICAL INC stock shows the neutral signal. See more of COLLEGIUM PHARMACEUTICAL INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.